journal article·2008-05

The dependence of in vivo stable ectopic chondrogenesis by human mesenchymal stem cells on chondrogenic differentiation in vitro

Kai Liu, Guang Dong Zhou, Wei Liu, Wen Jie Zhang, Lei Cui, Xia Liu, Tian Yi Liu, Yilin Cao

Biomaterials· Volume 29· Issue 14
Publisher page

Abstract

In vivo niche plays an important role in determining the fate of implanted mesenchymal stem cells (MSCs) by directing committed differentiation. An inappropriate in vivo niche can also alter desired ultimate fate of exogenous MSCs even they are in vitro induced to express a specific phenotype before in vivo implantation. Studies have shown that in vitro chondrogenically differentiated MSCs are apt to lose their phenotype and fail to form stable cartilage in subcutaneous environment. We hypothesized that failure of maintaining the phenotype of induced MSCs in subcutaneous environment is due to the insufficient chondrogenic differentiation in vitro and fully differentiated MSCs can retain their chondrocyte-like phenotype and form stable ectopic cartilage. To test this hypothesis, extended in vitro chondrogenic induction and cartilage formation were carried out before implantation. Human bone marrow stem cells (hBMSCs) were seeded onto polylactic acid coated polyglycolic acid scaffolds. The cell-scaffold constructs were chondrogenically induced from 4 to 12 weeks for in vitro chondrogenesis, and then implanted subcutaneously into nude mice for 12 or 24 weeks. The engineered cartilages were evaluated by gross view, glycosaminoglycan content measurement, and histological staining before and after implantation. Histological examination showed typical cartilage structure formation after 8 weeks of induction in vitro. However, part of the constructs became ossified after implantation when in vitro induction lasted 8 weeks or less time. In contrast, those induced for 12 weeks in vitro could retain their cartilage structure after in vivo implantation. These results indicate that a fully differentiated stage achieved by extended chondrogenic induction in vitro is necessary for hBMSCs to form stable ectopic chondrogenesis in vivo.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Mesenchymal stem cell research · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion10.1016/j.ejcts.2006.02.070 ↗
2. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study10.1007/s00424-006-0117-y ↗
3. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium10.1016/j.ejheart.2004.09.019 ↗
4. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix10.1089/ten.2006.12.3405 ↗
5. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model10.1089/ten.2006.12.1539 ↗
6. Differentiation of transplanted mesenchymal stem cells in a large osteochondral defect in rabbit10.1080/14653240500361350 ↗
7. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect10.1002/jemt.10111 ↗
8. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model10.2143/AC.60.3.2005005 ↗
9. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells10.1161/01.CIR.0000167553.49133.81 ↗
10. Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells10.1089/ten.2006.12.3209 ↗
11. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair10.1038/sj.gt.3302938 ↗
12. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo10.1002/art.11450 ↗
13. Multipotent mesenchymal stem cells from adult human synovial membrane10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P ↗
14. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice10.1002/art.22136 ↗
15. Preconditioning of mesenchymal stem cells with low-intensity ultrasound for cartilage formation in vivo10.1089/ten.2006.0080 ↗
16. Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model10.1089/ten.2005.11.1421 ↗
17. Characteristics of tissue-engineered cartilage from human auricular chondrocytes10.1016/j.biomaterials.2003.09.019 ↗
18. Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo10.1016/S0014-4827(03)00036-3 ↗
19. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I ↗
20. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F ↗
21. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
22. Growth factor combination for chondrogenic induction from human mesenchymal stem cell10.1016/j.bbrc.2004.06.029 ↗
23. Bridging tendon defects using autologous tenocyte engineered tendon in a hen model
24. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue10.1006/abio.1993.1197 ↗
25. In situ compressive properties of the glenoid labrum10.1002/1097-4636(20000915)51:4<711::AID-JBM20>3.0.CO;2-Z ↗
26. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells10.1634/stemcells.22-1-74 ↗
27. In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel10.1097/01.prs.0000236896.22479.52 ↗
28. Ectopic cartilage formation induced by mesenchymal stem cells on porous gelatin-chondroitin-hyaluronate scaffold containing microspheres loaded with TGF-beta110.1177/039139880602900610 ↗
29. Identification of a discrete population of human bone marrow-derived mesenchymal cells exhibiting properties of uncommitted progenitors10.1089/152581601317210845 ↗
30. Mesenchymal stem cells10.1177/153537020122600603 ↗
31. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model10.1242/jcs.113.7.1161 ↗
32. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol, in press.
33. Matrix remodeling during endochondral ossification10.1016/j.tcb.2003.12.003 ↗
34. Role of the subchondral vascular system in endochondral ossification: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro10.1016/S0945-053X(01)00132-9 ↗
35. Angiogenesis in osteoarthritis and spondylosis: successful repair with undesirable outcomes10.1097/01.bor.0000133662.60223.ee ↗
36. Osteoarthritis, angiogenesis and inflammation10.1093/rheumatology/keh344 ↗
37. Vascular mechanisms in osteoarthritis10.1053/berh.2001.0188 ↗
38. Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation10.1053/joca.2001.0450 ↗
39. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis
40. Troponin I is present in human cartilage and inhibits angiogenesis10.1073/pnas.96.6.2645 ↗
41. Troponin I peptide (Glu94-Leu123), a cartilage-derived angiogenesis inhibitor: in vitro and in vivo effects on human endothelial cells and on pancreatic cancer10.1016/j.gassur.2003.08.003 ↗
42. Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue10.1023/A:1014546909573 ↗
43. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures10.1089/ten.2006.12.691 ↗
44. Phenotypic plasticity of human articular chondrocytes10.2106/00004623-200300002-00012 ↗
45. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T ↗
46. VEGF: an essential mediator of both angiogenesis and endochondral ossification10.1177/154405910708601006 ↗
47. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation10.1242/jcs.113.1.59 ↗
48. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation10.1038/9467 ↗